Collegium to Participate in H.C. Wainwright 26th Annual Global Investment Conference
Collegium Pharmaceutical (Nasdaq: COLL) has announced its participation in the H.C. Wainwright 26th Annual Global Investment Conference in New York, NY from September 9-11, 2024. The company's management will engage in a fireside chat on Monday, September 9, 2024, at 12:30 p.m. ET.
As a leading diversified specialty pharmaceutical company, Collegium is dedicated to improving the lives of people with serious medical conditions. The fireside chat will be webcast live and can be accessed through the Investors section of Collegium's website. A replay of the webcast will remain available on the company's website for 90 days following the presentation, providing investors and interested parties with extended access to the discussion.
Collegium Pharmaceutical (Nasdaq: COLL) ha annunciato la sua partecipazione al 26° Convegno Globale di Investimento Annuale H.C. Wainwright a New York, NY, dal 9 all'11 settembre 2024. La direzione dell'azienda parteciperà a un fireside chat lunedì 9 settembre 2024, alle 12:30 ET.
Come azienda farmaceutica specializzata e diversificata leader, Collegium è dedicata a migliorare la vita delle persone con gravi problemi di salute. Il fireside chat sarà trasmesso in diretta streaming e sarà accessibile attraverso la sezione Investitori del sito web di Collegium. Una registrazione del webcast sarà disponibile sul sito dell'azienda per 90 giorni dopo la presentazione, offrendo così agli investitori e alle parti interessate un'accesso prolungato alla discussione.
Collegium Pharmaceutical (Nasdaq: COLL) ha anunciado su participación en el 26° Conferencia Anual Global de Inversión de H.C. Wainwright en Nueva York, NY, del 9 al 11 de septiembre de 2024. La dirección de la empresa participará en un fireside chat el lunes 9 de septiembre de 2024, a las 12:30 p.m. ET.
Como una empresa farmacéutica especializada y diversificada líder, Collegium está dedicada a mejorar la vida de las personas con condiciones médicas graves. El fireside chat se transmitirá en vivo y se podrá acceder a través de la sección de Inversores en el sitio web de Collegium. Una repetición de la transmisión estará disponible en el sitio web de la empresa durante 90 días después de la presentación, proporcionando a los inversores y partes interesadas un acceso ampliado a la discusión.
콜레기움 제약 (Nasdaq: COLL)가 2024년 9월 9일부터 11일까지 뉴욕에서 열리는 H.C. 웨인라이트 제26회 연례 글로벌 투자 컨퍼런스에 참여한다고 발표했습니다. 회사의 경영진은 2024년 9월 9일 월요일 오후 12시 30분 ET에 파이어사이드 채팅에 참여할 예정입니다.
콜레기움은 치료가 필요한 중병을 앓고 있는 사람들의 삶을 개선하는 데 전념하는 선도적인 전문 제약 회사입니다. 파이어사이드 채팅은 실시간 스트리밍으로 방송되며 콜레기움 웹사이트의 투자자 섹션을 통해 접근할 수 있습니다. 웹캐스트 재생은 발표 후 90일 동안 회사 웹사이트에서 제공되어 투자자와 관심 있는 당사자가 논의에 대한 연장된 접근을 할 수 있도록 합니다.
Collegium Pharmaceutical (Nasdaq: COLL) a annoncé sa participation à la 26e Conférence Annuelle Mondiale d'Investissement H.C. Wainwright à New York, NY, du 9 au 11 septembre 2024. La direction de l'entreprise prendra part à un fireside chat le lundi 9 septembre 2024, à 12h30 ET.
En tant qu'entreprise pharmaceutique spécialisée et diversifiée de premier plan, Collegium s'engage à améliorer la vie des personnes atteintes de graves problèmes de santé. Le fireside chat sera diffusé en direct et pourra être consulté via la section Investisseurs du site web de Collegium. Un enregistrement de la diffusion restera disponible sur le site de l'entreprise pendant 90 jours après la présentation, offrant aux investisseurs et aux parties intéressées un accès prolongé à la discussion.
Collegium Pharmaceutical (Nasdaq: COLL) hat seine Teilnahme an der 26. jährlichen globalen Investorenkonferenz von H.C. Wainwright in New York, NY, vom 9. bis 11. September 2024, bekannt gegeben. Das Management des Unternehmens wird am Montag, dem 9. September 2024, um 12:30 Uhr ET an einem Fireside Chat teilnehmen.
Als führendes, diversifiziertes Spezialpharmaunternehmen widmet sich Collegium der Verbesserung des Lebens von Menschen mit schweren gesundheitlichen Problemen. Der Fireside Chat wird live gestreamt und kann über den Investorenbereich der Collegium-Website aufgerufen werden. Eine Wiederholung des Webcasts wird 90 Tage nach der Präsentation auf der Website des Unternehmens verfügbar sein und Investoren sowie anderen Interessierten extended access zur Diskussion bieten.
- None.
- None.
STOUGHTON, Mass., Aug. 30, 2024 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a leading, diversified specialty pharmaceutical company committed to improving the lives of people living with serious medical conditions, today announced that management will participate in a fireside chat at the H.C. Wainwright 26th Annual Global Investment Conference being held in New York, NY from September 9-11, 2024.
Details of the event are as follows:
Fireside Chat Date and Time: Monday, September 9, 2024, at 12:30 p.m. ET
The fireside chat will be webcast live and can be accessed from the Investors section of the Company's website: https://ir.collegiumpharma.com A replay of the webcast will be archived on the Company's website for 90 days following the presentation.
About Collegium Pharmaceutical, Inc.
Collegium is a leading, diversified specialty pharmaceutical company committed to improving the lives of people living with serious medical conditions. Collegium’s headquarters are located in Stoughton, Massachusetts. For more information, please visit the Company’s website at www.collegiumpharma.com.
Investor Contact:
Christopher James, M.D.
Vice President, Investor Relations
ir@collegiumpharma.com
Media Contact:
Marissa Samuels
Vice President, Corporate Communications
communications@collegiumpharma.com 
FAQ
When is Collegium Pharmaceutical (COLL) participating in the H.C. Wainwright Global Investment Conference?
How can investors access Collegium Pharmaceutical's (COLL) fireside chat at the H.C. Wainwright conference?
How long will the replay of Collegium Pharmaceutical's (COLL) fireside chat be available?
What is the focus of Collegium Pharmaceutical (COLL) as a company?
